Back to WA Weiss Asset Management LP

BRBRIDGEBIO PHARMA INC

Showing 2 of 9 quarters

Position history for WAWeiss Asset Management LP's holdings in BRIDGEBIO PHARMA INC

No. Weiss Asset Management exited its BRIDGEBIO PHARMA position in Q1 2025. Its Q4 2024 13F listed 41,945,000 shares worth $35.9M. Weiss Asset Management first reported BRIDGEBIO PHARMA in Q1 2023 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$35.9M

Total Shares Change

-41.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
Decreased
41.9M
-43.7%
$35.9M0.7%—
0

Optional analytics helps us improve. How it’s used